Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Apoptosis. 2015 Sep;20(9):1200–1210. doi: 10.1007/s10495-015-1144-y

Fig. 6.

Fig. 6

Effects of ouabain on phosphorylation of the mitogen-activated protein kinases in HUVEC and RAEC. A, Representative Western blots showing the effects of ouabain on the content of phosphorylated ERK1/2, JNK1/2 and p38 MAPK. HUVEC and RAEC were treated during 6 hr with 3 and 3,000 μM ouabain, respectively. B, Normalized changes in the immunoreactivity of phosphorylated ERK1/2, JNK1/2 and MAPK in ouabain-treated HUVEC and RAEC. The immunoreactivity of phosphorylated MAPKs in control cells, which were not treated with ouabain, was taken as 1.00. Means ± S.E. from 3 experiments are shown.